Adline Chem Lab Limited reported a return to profitability in its first quarter of FY27, posting a net profit after tax of ₹4.01 lakh for the quarter ended June 30, 2026. This marks a significant turnaround from the net loss of ₹5.13 lakh recorded in the same quarter of the previous fiscal year.

Revenue from operations rose to ₹11.99 lakh, compared to nil revenue reported in Q1FY26. The company’s basic and diluted earnings per share (EPS) were negative at (₹0.17) per equity share of face value ₹10 each, reflecting cumulative losses despite the current quarter's profit.

Financial Performance

The company generated a pre-tax profit of ₹3.20 lakh before exceptional items, up from a loss of ₹5.87 lakh in Q1FY25. For the full financial year ended March 31, 2026, Adline Chem Lab had reported a net loss of ₹28.11 lakh on revenue of ₹1.15 lakh.

What the Numbers Show

A notable divergence exists between the current quarter’s operational performance and the company’s regulatory compliance status. While Adline Chem Lab achieved a pre-tax profit of ₹3.20 lakh, it simultaneously incurred a penalty of ₹1.06 lakh imposed by the BSE for the non-appointment of a Company Secretary during the quarter. This penalty was included in other expenses, indicating that governance costs directly impacted the bottom line even as operational revenues improved.

Governance and Compliance

The unaudited standalone financial results were reviewed by the Audit Committee and approved by the Board of Directors on August 13, 2026. The statutory auditors carried out a limited review of the results, with no qualifications or modifications noted in their report.

The company has not disclosed segment information as Ind AS 108 is not applicable. The figures for the quarter ended March 31, 2026, represent balancing figures between audited full-year data and published year-to-date figures.

Adline Chem Lab Ltd accepted the resignations of Independent Directors Mr. Him Vyas and Mr. Krish Patel, effective June 12, 2026, due to pre-existing personal commitments and unexpected professional constraints. The company confirmed that both directors have vacated their positions on the board with effect from the close of business hours on the specified date.

The resignations were intimated to BSE Limited pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company disclosed that it received confirmation from both directors stating there are no other material reasons for their resignation beyond those cited in their letters.

Resignation Details

The following table outlines the key particulars regarding the cessation of directorship for both individuals:

The company has arranged to submit the necessary forms to the Registrar of Companies (ROC), Ahmedabad, and has intimated the stock exchange regarding the change in board composition. The resignations were signed and submitted by Vrushank Balkrushna Patel, Managing Director of Adline Chem Lab Limited.